Medical Equipment

Epigenetics Diagnostics Market Growth Outlook Indicating Expansion To $35.17 Billion By 2030

May 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Growth In Market Value Is Anticipated For The Epigenetics Diagnostics Market Between 2026 And 2030?

The epigenetics diagnostics market size has experienced rapid growth in recent years. This market is forecasted to increase from $16.56 billion in 2025 to $19.29 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.5%. The historical expansion of the market can be attributed to factors such as the limited availability of epigenetic diagnostic tools, a reliance on conventional molecular biology methods, growing awareness of epigenetic research, increasing academic and clinical research activities, and the slow adoption of automated instrumentation.

The epigenetics diagnostics market is anticipated to experience substantial growth over the next few years. It is projected to expand to $35.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.2%. This projected increase is largely due to advancements in sequencing and epigenetic analysis technologies, escalating investments in personalized medicine, the expansion of diagnostics for oncology and metabolic diseases, the integration of cloud-based bioinformatics services, and a heightened demand from pharmaceutical and biotechnology companies. Significant trends for the upcoming period include the wider adoption of epigenetic biomarker kits, an increase in the use of next-generation sequencing and microarray systems, the broadening of data analysis and bioinformatics services, an intensified focus on oncology and personalized medicine applications, and the incorporation of automated liquid handling and high-throughput platforms.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27286&type=smp

What Important Drivers Are Powering The Epigenetics Diagnostics Market Growth?

The epigenetics diagnostics market is anticipated to expand in the future due to the increasing demand for personalized medicine. This approach customizes medical treatment based on an individual’s genetic makeup, biology, and lifestyle factors. The rising demand for personalized medicine is driven by advancements in genetic and molecular profiling, which enable treatments tailored to an individual’s unique biological makeup, thereby improving effectiveness and reducing side effects. Epigenetics diagnostics supports personalized medicine by identifying individual epigenetic patterns that guide customized prevention and treatment plans for optimal patient outcomes. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Thus, the growing demand for personalized medicine is a key driver of the epigenetics diagnostics market.

How Is The Epigenetics Diagnostics Market Structured Across Different Market Segments?

The epigenetics diagnostics market covered in this report is segmented –

1) By Product: Kits And Reagents, Software And Services, Instruments

2) By Technology: Deoxyribonucleic Acid (DNA) Methylation, Histone Methylation, Histone Acetylation, Large NonCoding, Ribonucleic Acid (RNA), Micro Ribonucleic Acid (RNA) Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End User: Pharmaceutical And Biotechnology firms, Academic And Research Institutes, Clinical Diagnostic Laboratories

Subsegments:

1) By Kits and Reagents: Deoxyribonucleic Acid Methylation Kits, Histone Modification Kits, Chromatin Accessibility Kits, Bisulfite Conversion Kits, Polymerase Chain Reaction Reagents, Antibodies and Probes, Enzymes and Buffers

2) By Software and Services: Data Analysis Software, Bioinformatics Services, Epigenetic Data Interpretation, Cloud-based Data Storage, Custom Assay Development, Validation and Consulting Services

3) By Instruments: Next-Generation Sequencers, Microarray Systems, Polymerase Chain Reaction and Quantitative Polymerase Chain Reaction Instruments, Mass Spectrometry Systems, Imaging Systems, Automation and Liquid Handling Systems

What Trends Are Influencing The Epigenetics Diagnostics Market?

Leading companies in the epigenetics diagnostics market are concentrating on developing innovative strategies, such as clinical-grade epigenetic analysis, to enhance the accuracy, sensitivity, and practical application in identifying disease-related epigenetic modifications. Clinical-grade epigenetic analysis refers to the utilization of validated and standardized methods for detecting epigenetic changes with the precision and reliability necessary for clinical diagnosis and treatment decisions. For instance, in October 2024, EpiMedTech, a Singapore-based biotechnology company, introduced epiGeneComplete, a clinical-grade test that integrates genetic and epigenetic analysis through next-generation sequencing and advanced DNA methylation techniques to provide detailed insights into key health indicators, including aging, stress, inflammation, addiction risk, and metabolism. Conducted in CAP-accredited laboratories, this non-invasive saliva-based test offers high sensitivity and accuracy, supports personalized health profiling, and is designed as an open, adaptable platform for future diagnostic expansion, marking a notable advancement in routine health screening and early disease detection.

Which Firms Are Competing In The Epigenetics Diagnostics Market?

Major companies operating in the epigenetics diagnostics market are F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., GeneTex Inc., Bio-Techne Corporation, Promega Corporation, New England Biolabs Incorporated, Pacific Biosciences of California Inc., Enzo Biochem Inc., Diagenode Société Anonyme, Zymo Research Corporation, Active Motif Inc., ADmit Therapeutics SL, Epigentek Group Inc., INHERENT Biosciences Inc.

Access The Complete Epigenetics Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/epigenetics-diagnostics-global-market-report

Which Regional Market Leads The Epigenetics Diagnostics Market?

North America was the largest region in the epigenetics diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epigenetics diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Epigenetics Diagnostics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=27286&type=smp

Browse Through More Reports Similar to the Global Epigenetics Diagnostics Market 2026, By The Business Research Company

Microfinance Market Report 2026

https://www.thebusinessresearchcompany.com/report/microfinance-global-market-report

Cloud Based Financial Platform Market Report 2026

https://www.thebusinessresearchcompany.com/report/cloud-based-financial-platform-global-market-report

Investments Market Report 2026

https://www.thebusinessresearchcompany.com/report/investments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795